Intravenous system for delivering a beneficial agent

• US 4,511,353 A
• Filed: 10/09/1981
• Issued: 04/16/1985
• Est. Priority Date: 07/13/1981
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Theeuwes, Felix
• Primary Examiner(s): Padgett, Ben R.
• Assistant Examiner(s): Wallen, T. J.
• Application Number:
  US06/310,047
• Time in Patent Office: 1,285 Days
• Field of Search: 604/83, 604/84, 604/85, 604/416, 604/890, 604/892, 604/56, 604/80, 604/81, 604/251, 604/252
• US Class Current: 604/85
• CPC Class Codes: A61M 5/1407 Infusion of two or more substances

Abstract

A formulation chamber is disclosed comprising a wall surrounding a lumen containing a device for delivering a beneficial agent. The chamber has an inlet for admitting a fluid into the chamber and an outlet for letting an agent formulation leave the chamber. The chamber is adapted for use in an intravenous delivery system for delivering an agent formulation to a patient.

Claims

1. A self-contained, self-powered beneficial, drug delivery system for use with an intravenous delivery system, the beneficial drug delivery system, comprising in combination:

(a) an intravenous formulation chamber comprising;

a wall provided with an inlet that lets an intravenously acceptable medical fluid into the intravenous formulation chamber, and with an outlet for letting fluid leave the chamber; and

,

(b) a drug delivery device in the intravenous formulation chamber, the device comprising an inner mass transfer conductor;

a beneficial intravenously administrable drug in an amount for performing a therapeutic program with said intravenously administrable drug in the conductor that is permeable to the passage of the drug; and

, a membrane surrounding the conductor, which membrane release the drug in a therapeutically effective amount from the device into the medical fluid that is a pharmaceutically acceptable carrier for the drug and enters the intravenous, formulation chamber for formulating an intravenously administrable fluid drug formulation in situ that produces a beneficial effect, when administered intravenously to a recipient, over time.

2. The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein when the chamber is connected to an intravenous delivery system, the device delivers the drug at a rate controlled by the device into the medical fluid that flows from the intravenous system into the formulation chamber.

3. The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the mass transfer conductor is a solid.

4. The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the mass transfer conductor is a liquid.

5. The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the membrane is a release rate controlling membrane that release the drug by the process of diffusion.

6. The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the delivery device membrane is microporous.